On November 20, 2023, Atreca Inc (NASDAQ: BCEL) opened at $0.2259, higher 6.72% from the last session. During the day, the shares moved up to $0.27 and dropped to $0.2259 before settling in for the closing price of $0.22. Price fluctuations for BCEL have ranged from $0.19 to $2.05 over the past 52 weeks.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -1.05%. Company’s average yearly earnings per share was noted 31.75% at the time writing. With a float of $28.97 million, this company’s outstanding shares have now reached $32.35 million.
Considering the fact that the conglomerate employs 90 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is -819.61, operating margin of -12665.58, and the pretax margin is -12617.79.
Atreca Inc (BCEL) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Atreca Inc is 26.28%, while institutional ownership is 25.79%. The most recent insider transaction that took place on Oct 19, was worth 110,582. In this transaction Former 10% Owner of this company sold 274,739 shares at a rate of $0.40, taking the stock ownership to the 286,893 shares. Before that another transaction happened on Aug 02, when Company’s Chief Strategy Officer sold 5,487 for $0.95, making the entire transaction worth $5,225. This insider now owns 72,817 shares in total.
Atreca Inc (BCEL) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/29/2023, the company posted -$0.39 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.38) by -$0.01. This company achieved a net margin of -12617.79 while generating a return on equity of -83.28. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 31.75% per share during the next fiscal year.
Atreca Inc (NASDAQ: BCEL) Trading Performance Indicators
Check out the current performance indicators for Atreca Inc (BCEL). In the past quarter, the stock posted a quick ratio of 1.58. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 35.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.49, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Atreca Inc (BCEL)
Compared to the last year’s volume of 0.67 million, its volume of 0.65 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 29.91%. Additionally, its Average True Range was 0.04.
During the past 100 days, Atreca Inc’s (BCEL) raw stochastic average was set at 4.67%, which indicates a significant decrease from 41.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 162.91% in the past 14 days, which was higher than the 162.69% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2672, while its 200-day Moving Average is $0.8409. Nevertheless, the first resistance level for the watch stands at $0.2614 in the near term. At $0.2877, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.3055. If the price goes on to break the first support level at $0.2173, it is likely to go to the next support level at $0.1995. Should the price break the second support level, the third support level stands at $0.1732.
Atreca Inc (NASDAQ: BCEL) Key Stats
There are currently 39,296K shares outstanding in the company with a market cap of 9.24 million. Presently, the company’s annual sales total 0 K according to its annual income of -97,160 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -19,190 K.